— Know what they know.
Not Investment Advice
Also trades as: 1951.HK (HKSE) · $vol 4M

JXFGF OTC

Jinxin Fertility Group Limited
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +3.6% 3Y: -41.2% 5Y: -83.9%
$0.29
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 46 · $740.3M mcap · 2.11B float · 0.0001% daily turnover

Cash Flow Trends

Operating Cash Flow
$629M -8.1% ▼
5Y CAGR: +6.8%
Capital Expenditures
$262M -51.2% ▼
5Y CAGR: -1.1%
Free Cash Flow
$367M -28.2% ▼
5Y CAGR: +15.9%
Dividends Paid
$150M -1328.0% ▼
Buybacks
$51M +0.0% ▲
Net Change in Cash
-$121M +81.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$252M$340M$121M$345M$392M
Depreciation & Amort.$130M$170M$261M$285M$276M
Stock-Based Comp.$84M$76M$33M$53M$47M
Change in Working Capital-$76M-$200M$35M-$36M-$33M
Other Non-Cash Items-$23M-$32M$72M$38M-$53M
Operating Cash Flow$308M$343M$542M$684M$629M
— Investing Activities —
Capital Expenditures-$266M-$80M-$959M-$174M-$262M
Acquisitions (Net)-$287M-$1.3B-$899M-$96M-$204M
Investment Purchases-$12.4B-$8.1B-$8.9B-$2.8B-$1.3B
Investment Sales$14.3B$8.1B$9.2B$2.6B$1.5B
Other Investing-$229M-$240M$184M$65M$9M
Investing Cash Flow$1.2B-$1.6B-$1.4B-$375M-$293M
— Financing Activities —
Net Debt Issuance$135M$1M$1.4B-$1.7B-$13M
Stock Repurchased-$60M-$41M$0$0-$51M
Dividends Paid-$150M$0-$159M-$11M-$150M
Other Financing$19M-$61M-$819M-$275M-$244M
Financing Cash Flow-$56M$955M$460M-$950M-$458M
Net Change in Cash$1.4B-$275M-$359M-$639M-$121M
Cash End of Period$2.0B$1.7B$1.3B$691M$571M
Free Cash Flow$42M$264M-$418M$511M$367M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms